Biocon Biologics Secures Strong Market Access Coverage for Its Stelara Biosimilar in the United States
Biocon Ltd has secured multiple market access agreements for Yesintek (ustekinumab-kfce), its biosimilar to Stelara (ustekinumab).
Category: Biosimilars